Physician profile
Lora Boone
NPI 1134414915
$510.39
in general payments reported to CMS, 2019-2025
19 companies · $265 in 2025
The $265 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $13.46 · 2022: $18.26 · 2023: $49.92 · 2024: $41.51 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $356.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $107.96 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Exact Sciences Corporation | $63.85 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $43.06 | 2025 | |
| Inspire Medical Systems, INC. | $33.16 | 2025 | Inspire |
| Dexcom, INC. | $27.50 | 2023 | Dexcom G6 Transmitter |
| Janssen Pharmaceuticals, INC | $24.81 | 2019 | |
| Biotronik Nro, INC. | $21.17 | 2025 | Prospera |
| Lilly USA, LLC | $20.07 | 2025 | Mounjaro, Zepbound |
| Sanofi-Aventis U.S. LLC | $19.63 | 2025 | |
| Abbott Laboratories | $18.26 | 2022 | |
| Amgen INC. | $17.66 | 2019 | |
| Recor Medical INC | $16.55 | 2025 | Paradise Ultrasound Renal Denervation System |
| Otsuka America Pharmaceutical, INC. | $16.46 | 2025 | Rexulti |
| Novo Nordisk INC | $14.50 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $13.95 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $13.46 | 2020 | |
| Amarin Pharma, INC. | $13.24 | 2019 | |
| Shire North American Group INC | $12.90 | 2019 | |
| Genentech USA, INC. | $12.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lora Boone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.